Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$385M |
| 2 |
Microsoft
MSFT
|
+$368M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$298M |
| 4 |
Delta Air Lines
DAL
|
+$208M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 2 |
Tesla
TSLA
|
+$353M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$303M |
| 4 |
NVIDIA
NVDA
|
+$290M |
| 5 |
Boeing
BA
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.47% |
| 3 | Consumer Discretionary | 12.34% |
| 4 | Consumer Staples | 10.13% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
iShares Russell Top 200 Value ETF
IWX
$4.05B
| $222K | ﹤0.01% |
3,400
-5,300
| -61% | -$360K |
|
3052
Sight Sciences
SGHT
$302M
| $222K | ﹤0.01% |
66,000
+50,700
| +331% | +$333K |
|
|
ICD
3053
DELISTED
Independence Contract Drilling, Inc.
ICD
| $222K | ﹤0.01% |
73,978
+2,134
| +3% | +$6.26K |
|
|
DOMA
3054
DELISTED
Doma Holdings, Inc.
DOMA
| $222K | ﹤0.01% |
43,707
-400
| -0.9% | -$2.48K |
|
3055
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.79B
| $220K | ﹤0.01% |
+2,600
| New | +$231K |
|
|
SILV
3056
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| $220K | ﹤0.01% |
49,800
-188,341
| -79% | -$958K |
|
|
AFIB
3057
DELISTED
Acutus Medical Inc
AFIB
| $220K | ﹤0.01% |
315,400
-54,500
| -15% | -$35.3K |
|
3058
Rimini Street
RMNI
$447M
| $219K | ﹤0.01% |
99,422
-35,508
| -26% | -$108K |
|
|
SCHV
3059
Schwab US Large-Cap Value ETF
SCHV
$16.1B
| $219K | ﹤0.01% |
10,200
-18,000
| -64% | -$404K |
|
3060
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.17B
| $219K | ﹤0.01% |
+10,300
| New | +$230K |
|
3061
Vanguard Communication Services ETF
VOX
$5.73B
| $219K | ﹤0.01% |
2,084
-7,916
| -79% | -$856K |
|
3062
Equillium
EQ
$138M
| $217K | ﹤0.01% |
293,291
-98,940
| -25% | -$79.3K |
|
3063
Jasper Therapeutics
JSPR
$22M
| $217K | ﹤0.01% |
31,021
+25,211
| +434% | +$308K |
|
|
NCNA
3064
NuCana
NCNA
$5.58M
| $217K | ﹤0.01% |
71
-2
| -3% | -$7.14K |
|
3065
PureCycle Technologies
PCT
$1.38B
| $217K | ﹤0.01% |
+38,600
| New | +$362K |
|
3066
Karooooo
KARO
$2.04B
| $215K | ﹤0.01% |
+10,801
| New | +$253K |
|
3067
MVB Financial
MVBF
$395M
| $215K | ﹤0.01% |
+9,500
| New | +$224K |
|
3068
Cardiff Oncology
CRDF
$74.3M
| $214K | ﹤0.01% |
154,000
-157,290
| -51% | -$265K |
|
3069
Alerus Financial
ALRS
$844M
| $213K | ﹤0.01% |
11,700
-400
| -3% | -$7.52K |
|
|
SSY
3070
DELISTED
SunLink Health Systems
SSY
| $213K | ﹤0.01% |
266,478
-4,400
| -2% | -$4.07K |
|
|
BWAY
3071
Brainsway
BWAY
$602M
| $212K | ﹤0.01% |
105,000
+17,058
| +19% | +$26.4K |
|
3072
First Interstate BancSystem
FIBK
$3.7B
| $212K | ﹤0.01% |
+8,498
| New | +$222K |
|
3073
BrightView Holdings
BV
$988M
| $211K | ﹤0.01% |
+27,200
| New | +$217K |
|
3074
Nurix Therapeutics
NRIX
$2.61B
| $211K | ﹤0.01% |
+26,800
| New | +$245K |
|
3075
Simply Good Foods
SMPL
$989M
| $211K | ﹤0.01% |
+6,100
| New | +$219K |
|
Similar funds
Renaissance Technologies's Q3 2023 Portfolio in Review
As of Q3 2023, Renaissance Technologies held 4,329 positions worth $58.7B, down 15% from $69.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.34B in Q3 2023, closing 714 positions and reducing 1,794 holdings. Its most notable exit was Chevron, an estimated $185M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in D.R. Horton worth $125M.
- Renaissance Technologies's largest Q3 2023 buy was D.R. Horton: 1,159,438 shares worth $125M.
- Renaissance Technologies added most to Netflix in Q3 2023, an estimated $385M increase.
- Renaissance Technologies's biggest Q3 2023 reduction was Meta Platforms (Facebook), cutting an estimated $1.34B.
- Renaissance Technologies fully exited Chevron in Q3 2023, selling an estimated $185M.
- Renaissance Technologies's ten largest holdings make up 12% of its $58.7B portfolio in Q3 2023.
- Renaissance Technologies opened 464 new positions and closed 714 in Q3 2023.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $58.7B.
Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.